Specialty Pharmacy

How does a specialty pharmacy provider benefit Alpha-1 patients?

The insurance advantages are just the beginning.

ARALAST NP augmentation therapy is available from a network of specialty pharmacies which provide a wide range of homecare and other support services. Because these specialty pharmacy providers have comprehensive relationships with most insurance carriers, there is a good chance that ARALAST NP augmentation therapy will be reimbursed at an in-network rate. In addition, the specialty pharmacies offer consultation and management for insurance and reimbursement issues.

To learn more about the specialty pharmacies Baxter has selected for providing ARALAST NP augmentation therapy, visit the Home Care page or call 1-866-ARALAST (272-5278).

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the detailed Important Risk Information and the Full Prescribing Information

Please review the detailed Important Risk Information and the Full Prescribing Information